nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.074	0.13	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.0608	0.107	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—ANXA4—liver cancer	0.0561	0.0988	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0425	0.0749	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.0389	0.0685	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0349	0.0615	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—ANXA5—liver cancer	0.0322	0.0567	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.0319	0.0562	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—ANXA2—liver cancer	0.0295	0.0519	CbGpPWpGaD
Misoprostol—Dinoprostone—HPGDS—liver cancer	0.0182	1	CrCbGaD
Misoprostol—Embolism—Sorafenib—liver cancer	0.0131	0.0315	CcSEcCtD
Misoprostol—Neuropathy—Sorafenib—liver cancer	0.00787	0.019	CcSEcCtD
Misoprostol—PTGER2—Ovarian Infertility Genes—CDKN1B—liver cancer	0.00632	0.0111	CbGpPWpGaD
Misoprostol—Rectal disorder—Epirubicin—liver cancer	0.00631	0.0152	CcSEcCtD
Misoprostol—Anorectal disorder—Epirubicin—liver cancer	0.00589	0.0142	CcSEcCtD
Misoprostol—Rectal disorder—Doxorubicin—liver cancer	0.00584	0.0141	CcSEcCtD
Misoprostol—Dehydration—Sorafenib—liver cancer	0.00566	0.0137	CcSEcCtD
Misoprostol—Breast disorder—Sorafenib—liver cancer	0.0055	0.0133	CcSEcCtD
Misoprostol—Anorectal disorder—Doxorubicin—liver cancer	0.00545	0.0132	CcSEcCtD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00527	0.00928	CbGpPWpGaD
Misoprostol—Dysphagia—Sorafenib—liver cancer	0.00526	0.0127	CcSEcCtD
Misoprostol—Erectile dysfunction—Sorafenib—liver cancer	0.00484	0.0117	CcSEcCtD
Misoprostol—Embolism—Epirubicin—liver cancer	0.00482	0.0116	CcSEcCtD
Misoprostol—Pneumonia—Sorafenib—liver cancer	0.00471	0.0114	CcSEcCtD
Misoprostol—Acute coronary syndrome—Sorafenib—liver cancer	0.00462	0.0112	CcSEcCtD
Misoprostol—Myocardial infarction—Sorafenib—liver cancer	0.00459	0.0111	CcSEcCtD
Misoprostol—Neuropathy peripheral—Sorafenib—liver cancer	0.00459	0.0111	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00451	0.00795	CbGpPWpGaD
Misoprostol—Embolism—Doxorubicin—liver cancer	0.00446	0.0108	CcSEcCtD
Misoprostol—Epistaxis—Sorafenib—liver cancer	0.00442	0.0107	CcSEcCtD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00433	0.00762	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCR4—liver cancer	0.0043	0.00758	CbGpPWpGaD
Misoprostol—Vaginal haemorrhage—Epirubicin—liver cancer	0.00418	0.0101	CcSEcCtD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CCR4—liver cancer	0.00399	0.00703	CbGpPWpGaD
Misoprostol—Gingivitis—Epirubicin—liver cancer	0.00394	0.00952	CcSEcCtD
Misoprostol—Tinnitus—Sorafenib—liver cancer	0.00392	0.00947	CcSEcCtD
Misoprostol—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00387	0.00934	CcSEcCtD
Misoprostol—Glycosuria—Epirubicin—liver cancer	0.00382	0.00922	CcSEcCtD
Misoprostol—Immune system disorder—Sorafenib—liver cancer	0.0038	0.00917	CcSEcCtD
Misoprostol—Rigors—Epirubicin—liver cancer	0.00379	0.00915	CcSEcCtD
Misoprostol—Arrhythmia—Sorafenib—liver cancer	0.00376	0.00907	CcSEcCtD
Misoprostol—Alopecia—Sorafenib—liver cancer	0.00372	0.00897	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00371	0.00653	CbGpPWpGaD
Misoprostol—Gingivitis—Doxorubicin—liver cancer	0.00365	0.00881	CcSEcCtD
Misoprostol—Breast pain—Epirubicin—liver cancer	0.00355	0.00857	CcSEcCtD
Misoprostol—Glycosuria—Doxorubicin—liver cancer	0.00354	0.00853	CcSEcCtD
Misoprostol—Muscle spasms—Sorafenib—liver cancer	0.00352	0.0085	CcSEcCtD
Misoprostol—Rigors—Doxorubicin—liver cancer	0.00351	0.00847	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—CCR4—liver cancer	0.00344	0.00606	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR4—liver cancer	0.00342	0.00603	CbGpPWpGaD
Misoprostol—Anaemia—Sorafenib—liver cancer	0.00338	0.00817	CcSEcCtD
Misoprostol—Syncope—Sorafenib—liver cancer	0.00328	0.00793	CcSEcCtD
Misoprostol—Breast pain—Doxorubicin—liver cancer	0.00328	0.00793	CcSEcCtD
Misoprostol—Loss of consciousness—Sorafenib—liver cancer	0.00322	0.00777	CcSEcCtD
Misoprostol—Inflammation—Epirubicin—liver cancer	0.00319	0.0077	CcSEcCtD
Misoprostol—Hypertension—Sorafenib—liver cancer	0.00316	0.00763	CcSEcCtD
Misoprostol—Myalgia—Sorafenib—liver cancer	0.00312	0.00753	CcSEcCtD
Misoprostol—Arthralgia—Sorafenib—liver cancer	0.00312	0.00753	CcSEcCtD
Misoprostol—Pulmonary embolism—Epirubicin—liver cancer	0.0031	0.00747	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Epirubicin—liver cancer	0.0031	0.00747	CcSEcCtD
Misoprostol—Anaphylactic shock—Sorafenib—liver cancer	0.00299	0.00721	CcSEcCtD
Misoprostol—Infection—Sorafenib—liver cancer	0.00297	0.00717	CcSEcCtD
Misoprostol—Inflammation—Doxorubicin—liver cancer	0.00295	0.00713	CcSEcCtD
Misoprostol—Shock—Sorafenib—liver cancer	0.00294	0.0071	CcSEcCtD
Misoprostol—Thrombocytopenia—Sorafenib—liver cancer	0.00293	0.00706	CcSEcCtD
Misoprostol—Neuropathy—Epirubicin—liver cancer	0.00291	0.00702	CcSEcCtD
Misoprostol—Pulmonary embolism—Doxorubicin—liver cancer	0.00286	0.00691	CcSEcCtD
Misoprostol—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00286	0.00691	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—CCR4—liver cancer	0.00282	0.00497	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00272	0.00657	CcSEcCtD
Misoprostol—Abnormal vision—Epirubicin—liver cancer	0.0027	0.00652	CcSEcCtD
Misoprostol—Neuropathy—Doxorubicin—liver cancer	0.00269	0.00649	CcSEcCtD
Misoprostol—Dyspnoea—Sorafenib—liver cancer	0.00266	0.00643	CcSEcCtD
Misoprostol—Dyspepsia—Sorafenib—liver cancer	0.00263	0.00635	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CHN2—liver cancer	0.00262	0.00461	CbGpPWpGaD
Misoprostol—Phlebitis—Epirubicin—liver cancer	0.00261	0.0063	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—CCR4—liver cancer	0.0026	0.00459	CbGpPWpGaD
Misoprostol—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00258	0.00624	CcSEcCtD
Misoprostol—Fatigue—Sorafenib—liver cancer	0.00258	0.00622	CcSEcCtD
Misoprostol—Pain—Sorafenib—liver cancer	0.00256	0.00617	CcSEcCtD
Misoprostol—Constipation—Sorafenib—liver cancer	0.00256	0.00617	CcSEcCtD
Misoprostol—Vascular purpura—Epirubicin—liver cancer	0.00251	0.00606	CcSEcCtD
Misoprostol—Abnormal vision—Doxorubicin—liver cancer	0.0025	0.00603	CcSEcCtD
Misoprostol—Gastrointestinal pain—Sorafenib—liver cancer	0.00244	0.0059	CcSEcCtD
Misoprostol—Phlebitis—Doxorubicin—liver cancer	0.00241	0.00583	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—IFT88—liver cancer	0.00239	0.00422	CbGpPWpGaD
Misoprostol—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00239	0.00577	CcSEcCtD
Misoprostol—Body temperature increased—Sorafenib—liver cancer	0.00236	0.0057	CcSEcCtD
Misoprostol—Abdominal pain—Sorafenib—liver cancer	0.00236	0.0057	CcSEcCtD
Misoprostol—Purpura—Epirubicin—liver cancer	0.00233	0.00563	CcSEcCtD
Misoprostol—Vascular purpura—Doxorubicin—liver cancer	0.00232	0.00561	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00225	0.00542	CcSEcCtD
Misoprostol—Hypersensitivity—Sorafenib—liver cancer	0.0022	0.00532	CcSEcCtD
Misoprostol—Purpura—Doxorubicin—liver cancer	0.00216	0.00521	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CHN2—liver cancer	0.00215	0.00379	CbGpPWpGaD
Misoprostol—Asthenia—Sorafenib—liver cancer	0.00214	0.00518	CcSEcCtD
Misoprostol—Dehydration—Epirubicin—liver cancer	0.00209	0.00504	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00208	0.00502	CcSEcCtD
Misoprostol—Diarrhoea—Sorafenib—liver cancer	0.00204	0.00494	CcSEcCtD
Misoprostol—Breast disorder—Epirubicin—liver cancer	0.00203	0.0049	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—TRIO—liver cancer	0.00203	0.00357	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CHN2—liver cancer	0.00198	0.00349	CbGpPWpGaD
Misoprostol—Dizziness—Sorafenib—liver cancer	0.00198	0.00477	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—IFT88—liver cancer	0.00197	0.00346	CbGpPWpGaD
Misoprostol—Dysphagia—Epirubicin—liver cancer	0.00194	0.00469	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CCR4—liver cancer	0.00194	0.00342	CbGpPWpGaD
Misoprostol—Dehydration—Doxorubicin—liver cancer	0.00193	0.00467	CcSEcCtD
Misoprostol—Vomiting—Sorafenib—liver cancer	0.0019	0.00459	CcSEcCtD
Misoprostol—Rash—Sorafenib—liver cancer	0.00188	0.00455	CcSEcCtD
Misoprostol—Dermatitis—Sorafenib—liver cancer	0.00188	0.00454	CcSEcCtD
Misoprostol—Breast disorder—Doxorubicin—liver cancer	0.00188	0.00454	CcSEcCtD
Misoprostol—Headache—Sorafenib—liver cancer	0.00187	0.00452	CcSEcCtD
Misoprostol—Bronchitis—Epirubicin—liver cancer	0.00187	0.00451	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—TRIO—liver cancer	0.00184	0.00324	CbGpPWpGaD
Misoprostol—Dysuria—Epirubicin—liver cancer	0.00182	0.00438	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—IFT88—liver cancer	0.00181	0.0032	CbGpPWpGaD
Misoprostol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00181	0.00436	CcSEcCtD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.0018	0.00318	CbGpPWpGaD
Misoprostol—Dysphagia—Doxorubicin—liver cancer	0.0018	0.00434	CcSEcCtD
Misoprostol—Nausea—Sorafenib—liver cancer	0.00178	0.00429	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCR4—liver cancer	0.00176	0.00311	CbGpPWpGaD
Misoprostol—Pneumonia—Epirubicin—liver cancer	0.00174	0.0042	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—liver cancer	0.00173	0.00418	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—liver cancer	0.00173	0.00417	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—liver cancer	0.0017	0.0041	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—liver cancer	0.00168	0.00406	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—liver cancer	0.00168	0.00406	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—liver cancer	0.00168	0.00406	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00167	0.00403	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—TRIO—liver cancer	0.00166	0.00293	CbGpPWpGaD
Misoprostol—Haematuria—Epirubicin—liver cancer	0.00165	0.00399	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—liver cancer	0.00163	0.00394	CcSEcCtD
Misoprostol—Pneumonia—Doxorubicin—liver cancer	0.00161	0.00389	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—liver cancer	0.0016	0.00387	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CCR4—liver cancer	0.00159	0.00281	CbGpPWpGaD
Misoprostol—Neuropathy peripheral—Doxorubicin—liver cancer	0.00157	0.00379	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—liver cancer	0.00156	0.00376	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—liver cancer	0.00156	0.00376	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—TRIO—liver cancer	0.00154	0.0027	CbGpPWpGaD
Misoprostol—Haematuria—Doxorubicin—liver cancer	0.00153	0.00369	CcSEcCtD
Misoprostol—Epistaxis—Doxorubicin—liver cancer	0.00151	0.00365	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—TRIO—liver cancer	0.00151	0.00266	CbGpPWpGaD
Misoprostol—Visual impairment—Epirubicin—liver cancer	0.0015	0.00362	CcSEcCtD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00148	0.00261	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CCR4—liver cancer	0.00147	0.00259	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SHC3—liver cancer	0.00147	0.00258	CbGpPWpGaD
Misoprostol—Tinnitus—Epirubicin—liver cancer	0.00145	0.0035	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CCR4—liver cancer	0.00145	0.00255	CbGpPWpGaD
Misoprostol—Immune system disorder—Epirubicin—liver cancer	0.0014	0.00339	CcSEcCtD
Misoprostol—Chills—Epirubicin—liver cancer	0.0014	0.00337	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—TRIO—liver cancer	0.00139	0.00246	CbGpPWpGaD
Misoprostol—Arrhythmia—Epirubicin—liver cancer	0.00139	0.00335	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—liver cancer	0.00139	0.00335	CcSEcCtD
Misoprostol—Alopecia—Epirubicin—liver cancer	0.00137	0.00332	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—F2—liver cancer	0.00137	0.00242	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.00137	0.00241	CbGpPWpGaD
Misoprostol—Tinnitus—Doxorubicin—liver cancer	0.00134	0.00324	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCR4—liver cancer	0.00134	0.00235	CbGpPWpGaD
Misoprostol—Flatulence—Epirubicin—liver cancer	0.00133	0.00322	CcSEcCtD
Misoprostol—Back pain—Epirubicin—liver cancer	0.00131	0.00316	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—liver cancer	0.0013	0.00314	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—liver cancer	0.0013	0.00314	CcSEcCtD
Misoprostol—Chills—Doxorubicin—liver cancer	0.00129	0.00312	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—liver cancer	0.00129	0.0031	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—liver cancer	0.00127	0.00307	CcSEcCtD
Misoprostol—Anaemia—Epirubicin—liver cancer	0.00125	0.00302	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—liver cancer	0.00123	0.00298	CcSEcCtD
Misoprostol—Syncope—Epirubicin—liver cancer	0.00121	0.00293	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—liver cancer	0.00121	0.00292	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—SHC3—liver cancer	0.0012	0.00212	CbGpPWpGaD
Misoprostol—Muscle spasms—Doxorubicin—liver cancer	0.0012	0.00291	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—liver cancer	0.00119	0.00287	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—liver cancer	0.00117	0.00282	CcSEcCtD
Misoprostol—Anaemia—Doxorubicin—liver cancer	0.00116	0.00279	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—liver cancer	0.00115	0.00278	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—liver cancer	0.00115	0.00278	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—liver cancer	0.00115	0.00278	CcSEcCtD
Misoprostol—Anxiety—Epirubicin—liver cancer	0.00115	0.00277	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FST—liver cancer	0.00114	0.00201	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—F2—liver cancer	0.00113	0.00199	CbGpPWpGaD
Misoprostol—Syncope—Doxorubicin—liver cancer	0.00112	0.00271	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PRKCE—liver cancer	0.00112	0.00197	CbGpPWpGaD
Misoprostol—Confusional state—Epirubicin—liver cancer	0.00111	0.00269	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—SHC3—liver cancer	0.00111	0.00196	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Epirubicin—liver cancer	0.0011	0.00267	CcSEcCtD
Misoprostol—Oedema—Epirubicin—liver cancer	0.0011	0.00267	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—liver cancer	0.0011	0.00266	CcSEcCtD
Misoprostol—Infection—Epirubicin—liver cancer	0.0011	0.00265	CcSEcCtD
Misoprostol—Shock—Epirubicin—liver cancer	0.00109	0.00262	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—TRIO—liver cancer	0.00109	0.00191	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Epirubicin—liver cancer	0.00108	0.00261	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—liver cancer	0.00108	0.00261	CcSEcCtD
Misoprostol—Hyperhidrosis—Epirubicin—liver cancer	0.00107	0.00258	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—liver cancer	0.00107	0.00257	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—liver cancer	0.00107	0.00257	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—liver cancer	0.00107	0.00257	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—liver cancer	0.00106	0.00256	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CCR4—liver cancer	0.00104	0.00184	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—F2—liver cancer	0.00104	0.00183	CbGpPWpGaD
Misoprostol—Hypotension—Epirubicin—liver cancer	0.00103	0.00249	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—liver cancer	0.00103	0.00249	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—liver cancer	0.00102	0.00247	CcSEcCtD
Misoprostol—Anaphylactic shock—Doxorubicin—liver cancer	0.00102	0.00247	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PRKCE—liver cancer	0.00102	0.00179	CbGpPWpGaD
Misoprostol—Infection—Doxorubicin—liver cancer	0.00102	0.00245	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00101	0.00243	CcSEcCtD
Misoprostol—Shock—Doxorubicin—liver cancer	0.00101	0.00243	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—liver cancer	0.001	0.00242	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CSF2—liver cancer	0.000989	0.00174	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Doxorubicin—liver cancer	0.000988	0.00238	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—liver cancer	0.000985	0.00238	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—liver cancer	0.000982	0.00237	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—liver cancer	0.000972	0.00235	CcSEcCtD
Misoprostol—Hypotension—Doxorubicin—liver cancer	0.000955	0.00231	CcSEcCtD
Misoprostol—Fatigue—Epirubicin—liver cancer	0.000952	0.0023	CcSEcCtD
Misoprostol—Pain—Epirubicin—liver cancer	0.000945	0.00228	CcSEcCtD
Misoprostol—Constipation—Epirubicin—liver cancer	0.000945	0.00228	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FST—liver cancer	0.000935	0.00165	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000931	0.00225	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PRKCE—liver cancer	0.000918	0.00162	CbGpPWpGaD
Misoprostol—Dyspnoea—Doxorubicin—liver cancer	0.000911	0.0022	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—liver cancer	0.00091	0.0022	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—liver cancer	0.000909	0.00219	CcSEcCtD
Misoprostol—Gastrointestinal pain—Epirubicin—liver cancer	0.000903	0.00218	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—liver cancer	0.0009	0.00217	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CSF2—liver cancer	0.000898	0.00158	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TRIO—liver cancer	0.000892	0.00157	CbGpPWpGaD
Misoprostol—Fatigue—Doxorubicin—liver cancer	0.000881	0.00213	CcSEcCtD
Misoprostol—Pain—Doxorubicin—liver cancer	0.000874	0.00211	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—liver cancer	0.000874	0.00211	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—liver cancer	0.000873	0.00211	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—liver cancer	0.000873	0.00211	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FST—liver cancer	0.000863	0.00152	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCR4—liver cancer	0.000855	0.00151	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PRKCE—liver cancer	0.000847	0.00149	CbGpPWpGaD
Misoprostol—Feeling abnormal—Doxorubicin—liver cancer	0.000842	0.00203	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—liver cancer	0.000836	0.00202	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PRKCE—liver cancer	0.000834	0.00147	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ADAM17—liver cancer	0.000823	0.00145	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TRIO—liver cancer	0.000823	0.00145	CbGpPWpGaD
Misoprostol—Hypersensitivity—Epirubicin—liver cancer	0.000814	0.00196	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CSF2—liver cancer	0.000812	0.00143	CbGpPWpGaD
Misoprostol—Body temperature increased—Doxorubicin—liver cancer	0.000808	0.00195	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—liver cancer	0.000808	0.00195	CcSEcCtD
Misoprostol—Asthenia—Epirubicin—liver cancer	0.000793	0.00191	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCR4—liver cancer	0.00079	0.00139	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—F2—liver cancer	0.000776	0.00137	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PSMD10—liver cancer	0.000774	0.00136	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PSMA4—liver cancer	0.000774	0.00136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PRKCE—liver cancer	0.00077	0.00136	CbGpPWpGaD
Misoprostol—Diarrhoea—Epirubicin—liver cancer	0.000756	0.00182	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—liver cancer	0.000753	0.00182	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CSF2—liver cancer	0.00075	0.00132	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CG—liver cancer	0.000743	0.00131	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CSF2—liver cancer	0.000738	0.0013	CbGpPWpGaD
Misoprostol—Asthenia—Doxorubicin—liver cancer	0.000733	0.00177	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—liver cancer	0.00073	0.00176	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—F2—liver cancer	0.000705	0.00124	CbGpPWpGaD
Misoprostol—Vomiting—Epirubicin—liver cancer	0.000702	0.0017	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—liver cancer	0.000699	0.00169	CcSEcCtD
Misoprostol—Rash—Epirubicin—liver cancer	0.000696	0.00168	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—liver cancer	0.000696	0.00168	CcSEcCtD
Misoprostol—Headache—Epirubicin—liver cancer	0.000692	0.00167	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CSF2—liver cancer	0.000681	0.0012	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ADAM17—liver cancer	0.000676	0.00119	CbGpPWpGaD
Misoprostol—Dizziness—Doxorubicin—liver cancer	0.000676	0.00163	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CG—liver cancer	0.000675	0.00119	CbGpPWpGaD
Misoprostol—Nausea—Epirubicin—liver cancer	0.000656	0.00158	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CD—liver cancer	0.000653	0.00115	CbGpPWpGaD
Misoprostol—Vomiting—Doxorubicin—liver cancer	0.00065	0.00157	CcSEcCtD
Misoprostol—Rash—Doxorubicin—liver cancer	0.000644	0.00156	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—liver cancer	0.000644	0.00155	CcSEcCtD
Misoprostol—Headache—Doxorubicin—liver cancer	0.00064	0.00155	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—F2—liver cancer	0.000637	0.00112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PSMA4—liver cancer	0.000636	0.00112	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PSMD10—liver cancer	0.000636	0.00112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ADAM17—liver cancer	0.000624	0.0011	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CG—liver cancer	0.00061	0.00107	CbGpPWpGaD
Misoprostol—Nausea—Doxorubicin—liver cancer	0.000607	0.00147	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PRKCE—liver cancer	0.0006	0.00106	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CD—liver cancer	0.000593	0.00104	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—F2—liver cancer	0.000588	0.00104	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PSMD10—liver cancer	0.000587	0.00103	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PSMA4—liver cancer	0.000587	0.00103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—F2—liver cancer	0.000579	0.00102	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CB—liver cancer	0.000569	0.001	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF2—liver cancer	0.000568	0.001	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CG—liver cancer	0.000563	0.000992	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CG—liver cancer	0.000554	0.000976	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CD—liver cancer	0.000536	0.000945	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—F2—liver cancer	0.000534	0.000941	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CSF2—liver cancer	0.000531	0.000935	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—RAF1—liver cancer	0.000529	0.000933	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—H2AFX—liver cancer	0.000523	0.000922	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—IL2—liver cancer	0.000523	0.000921	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CB—liver cancer	0.000517	0.000911	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CG—liver cancer	0.000511	0.000901	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CD—liver cancer	0.000495	0.000872	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PRKCE—liver cancer	0.000493	0.000868	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CD—liver cancer	0.000487	0.000858	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL2—liver cancer	0.000475	0.000836	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TERT—liver cancer	0.000473	0.000833	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CB—liver cancer	0.000467	0.000824	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF2—liver cancer	0.000467	0.000822	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PRKCE—liver cancer	0.000455	0.000801	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CD—liver cancer	0.000449	0.000792	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CSF2—liver cancer	0.000436	0.000768	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—RAF1—liver cancer	0.000435	0.000766	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KDR—liver cancer	0.000433	0.000762	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CB—liver cancer	0.000431	0.00076	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF2—liver cancer	0.000431	0.000759	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK14—liver cancer	0.00043	0.000757	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—H2AFX—liver cancer	0.000429	0.000757	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—liver cancer	0.000429	0.000756	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CB—liver cancer	0.000424	0.000748	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ESR1—liver cancer	0.000422	0.000743	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—F2—liver cancer	0.000416	0.000734	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CSF2—liver cancer	0.000402	0.000709	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—RAF1—liver cancer	0.000401	0.000707	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CG—liver cancer	0.000398	0.000702	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—APC—liver cancer	0.000398	0.000702	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—H2AFX—liver cancer	0.000396	0.000698	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—liver cancer	0.000396	0.000698	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CB—liver cancer	0.000392	0.00069	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—liver cancer	0.00039	0.000687	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TERT—liver cancer	0.000388	0.000684	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BRAF—liver cancer	0.000375	0.00066	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—liver cancer	0.00036	0.000634	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TERT—liver cancer	0.000358	0.000632	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KDR—liver cancer	0.000355	0.000626	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK14—liver cancer	0.000353	0.000622	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CD—liver cancer	0.00035	0.000617	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PIK3CA—liver cancer	0.000347	0.000611	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SERPINE1—liver cancer	0.000346	0.000611	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—liver cancer	0.000346	0.00061	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—KRAS—liver cancer	0.000343	0.000604	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—F2—liver cancer	0.000342	0.000603	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KDR—liver cancer	0.000328	0.000578	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—APC—liver cancer	0.000327	0.000577	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CG—liver cancer	0.000327	0.000577	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK14—liver cancer	0.000326	0.000574	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ESR1—liver cancer	0.000319	0.000563	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—F2—liver cancer	0.000316	0.000556	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PIK3CA—liver cancer	0.000315	0.000555	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—RAF1—liver cancer	0.000313	0.000551	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BRAF—liver cancer	0.000308	0.000542	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MTOR—liver cancer	0.000305	0.000538	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CB—liver cancer	0.000305	0.000538	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CG—liver cancer	0.000302	0.000532	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—APC—liver cancer	0.000302	0.000532	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HRAS—liver cancer	0.000292	0.000514	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CD—liver cancer	0.000288	0.000507	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1B—liver cancer	0.000287	0.000505	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PIK3CA—liver cancer	0.000285	0.000502	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SERPINE1—liver cancer	0.000285	0.000501	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BRAF—liver cancer	0.000284	0.0005	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—AKT1—liver cancer	0.000283	0.000499	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—KRAS—liver cancer	0.000282	0.000496	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CASP3—liver cancer	0.000281	0.000495	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—liver cancer	0.00028	0.000494	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—liver cancer	0.000279	0.000492	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCND1—liver cancer	0.000273	0.000482	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—JUN—liver cancer	0.000273	0.000481	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CTNNB1—liver cancer	0.000271	0.000477	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CD—liver cancer	0.000265	0.000468	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MMP9—liver cancer	0.000265	0.000468	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CDKN1A—liver cancer	0.000264	0.000466	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PIK3CA—liver cancer	0.000263	0.000463	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SERPINE1—liver cancer	0.000263	0.000463	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—KRAS—liver cancer	0.00026	0.000458	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PIK3CA—liver cancer	0.000259	0.000456	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MAPK8—liver cancer	0.000258	0.000455	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—AKT1—liver cancer	0.000257	0.000454	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—RAF1—liver cancer	0.000257	0.000453	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CB—liver cancer	0.000251	0.000442	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MTOR—liver cancer	0.000251	0.000442	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HRAS—liver cancer	0.000239	0.000422	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PIK3CA—liver cancer	0.000239	0.000421	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—VEGFA—liver cancer	0.000238	0.00042	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RAF1—liver cancer	0.000237	0.000418	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—STAT3—liver cancer	0.000236	0.000416	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1B—liver cancer	0.000235	0.000415	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—AKT1—liver cancer	0.000233	0.00041	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CB—liver cancer	0.000231	0.000408	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MTOR—liver cancer	0.000231	0.000408	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CASP3—liver cancer	0.000231	0.000406	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—liver cancer	0.00023	0.000406	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—liver cancer	0.000229	0.000404	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCND1—liver cancer	0.000224	0.000396	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—JUN—liver cancer	0.000224	0.000395	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CTNNB1—liver cancer	0.000222	0.000392	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HRAS—liver cancer	0.000221	0.000389	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—liver cancer	0.000219	0.000386	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—liver cancer	0.000219	0.000385	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MMP9—liver cancer	0.000218	0.000384	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CDKN1A—liver cancer	0.000217	0.000383	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1B—liver cancer	0.000217	0.000383	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—AKT1—liver cancer	0.000215	0.000379	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CASP3—liver cancer	0.000213	0.000375	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—liver cancer	0.000213	0.000374	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MAPK8—liver cancer	0.000212	0.000373	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—liver cancer	0.000211	0.000373	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—AKT1—liver cancer	0.000211	0.000372	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCND1—liver cancer	0.000207	0.000365	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—JUN—liver cancer	0.000207	0.000364	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CTNNB1—liver cancer	0.000205	0.000362	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KRAS—liver cancer	0.000203	0.000357	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MMP9—liver cancer	0.000201	0.000354	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CDKN1A—liver cancer	0.0002	0.000353	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—VEGFA—liver cancer	0.000196	0.000345	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MAPK8—liver cancer	0.000196	0.000345	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—AKT1—liver cancer	0.000195	0.000344	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—STAT3—liver cancer	0.000194	0.000341	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PIK3CA—liver cancer	0.000186	0.000328	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—VEGFA—liver cancer	0.000181	0.000318	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TP53—liver cancer	0.00018	0.000317	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—liver cancer	0.00018	0.000317	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—liver cancer	0.00018	0.000317	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STAT3—liver cancer	0.000179	0.000315	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HRAS—liver cancer	0.000172	0.000303	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KRAS—liver cancer	0.000166	0.000293	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—liver cancer	0.000166	0.000293	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—liver cancer	0.000166	0.000292	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—liver cancer	0.000165	0.00029	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KRAS—liver cancer	0.000154	0.000271	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PIK3CA—liver cancer	0.000153	0.000269	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—AKT1—liver cancer	0.000152	0.000268	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TP53—liver cancer	0.000148	0.000261	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HRAS—liver cancer	0.000141	0.000249	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PIK3CA—liver cancer	0.000141	0.000249	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TP53—liver cancer	0.000136	0.00024	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—liver cancer	0.000135	0.000239	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HRAS—liver cancer	0.000131	0.00023	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—liver cancer	0.000125	0.00022	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—AKT1—liver cancer	0.000125	0.00022	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—AKT1—liver cancer	0.000115	0.000203	CbGpPWpGaD
